Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodies.
about
A novel interaction of pokeweed antiviral protein with translation initiation factors 4G and iso4G: a potential indirect mechanism to access viral RNAs.Chinese Herbal Medicine-induced Liver InjuryPokeweed antiviral protein, a ribosome inactivating protein: activity, inhibition and prospectsRibosome-inactivating proteins: from plant defense to tumor attackX-ray crystallographic analysis of the structural basis for the interactions of pokeweed antiviral protein with its active site inhibitor and ribosomal RNA substrate analogsX-ray crystallographic analysis of the structural basis for the interaction of pokeweed antiviral protein with guanine residues of ribosomal RNAThe crystal structure of saporin SO6 from Saponaria officinalis and its interaction with the ribosomeType-1 ribosome-inactivating protein from iris (Iris hollandica var. Professor Blaauw) binds specific genomic DNA fragmentsStructure-based design of novel dihydroalkoxybenzyloxopyrimidine derivatives as potent nonnucleoside inhibitors of the human immunodeficiency virus reverse transcriptaseSynthesis of dual function (5R,6R)- and (5S,6S)-5-bromo-6-methoxy-5,6-dihydro-AZT-5'-(para-bromophenyl methoxyalaninyl phosphate) as novel spermicidal and anti-HIV agentsAZT-5'-(p-bromophenyl methoxyalaninyl phosphate) as a potent and non-toxic anti-human immunodeficiency virus agentImportance of the alanine methyl ester side chain for the biological activity profile of dual-function phenyl phosphate derivatives of bromo-methoxy-zidovudineAnti-human immunodeficiency virus type 1 activity of an anti-CD4 immunoconjugate containing pokeweed antiviral proteinTXU (anti-CD7)-pokeweed antiviral protein as a potent inhibitor of human immunodeficiency virusIsolation and characterization of pokeweed antiviral protein mutations in Saccharomyces cerevisiae: identification of residues important for toxicityThe pokeweed antiviral protein specifically inhibits Ty1-directed +1 ribosomal frameshifting and retrotransposition in Saccharomyces cerevisiae.Pokeweed antiviral protein increases HIV-1 particle infectivity by activating the cellular mitogen activated protein kinase pathway.A novel mechanism for inhibition of translation by pokeweed antiviral protein: depurination of the capped RNA template.Pokeweed antiviral protein binds to the cap structure of eukaryotic mRNA and depurinates the mRNA downstream of the cap.Safety, activity, and pharmacokinetics of GLQ223 in patients with AIDS and AIDS-related complex.Structure-based design and engineering of a nontoxic recombinant pokeweed antiviral protein with potent anti-human immunodeficiency virus activityAntiviral therapy for human immunodeficiency virus infectionsRNase inhibition of human immunodeficiency virus infection of H9 cells.Virucidal effects of glucose oxidase and peroxidase or their protein conjugates on human immunodeficiency virus type 1.Combined use of an immunotoxin and cyclosporine to prevent both activated and quiescent peripheral blood T cells from producing type 1 human immunodeficiency virus.C-terminal deletion mutant of pokeweed antiviral protein inhibits viral infection but does not depurinate host ribosomes.Anti-HIV and anti-tumor protein MAP30, a 30 kDa single-strand type-I RIP, shares similar secondary structure and beta-sheet topology with the A chain of ricin, a type-II RIP.Broad-spectrum virus resistance in transgenic plants expressing pokeweed antiviral protein.Suppression of human T-cell leukemia virus I gene expression by pokeweed antiviral protein.TAP 29: an anti-human immunodeficiency virus protein from Trichosanthes kirilowii that is nontoxic to intact cells.RNA toxins: mediators of stress adaptation and pathogen defense.Ribosome inactivating proteins from plants inhibiting viruses.Biological activities of ribosome-inactivating proteins and their possible applications as antimicrobial, anticancer, and anti-pest agents and in neuroscience research.The future of antiviral immunotoxins.Pokeweed antiviral protein alters splicing of HIV-1 RNAs, resulting in reduced virus production.Inhibition of virus production in peripheral blood mononuclear cells from human immunodeficiency virus (HIV) type 1-seropositive donors by treatment with recombinant HIV-like particles.Mutations dissociating the inhibitory activity of the pokeweed antiviral protein on eukaryote translation and Escherichia coli growthAnti-HIV-1 property of trichosanthin correlates with its ribosome inactivating activity.Cytotoxic activity of a recombinant GnRH-PAP fusion toxin on human tumor cell lines.Purification, characterization and molecular cloning of trichoanguin, a novel type I ribosome-inactivating protein from the seeds of Trichosanthes anguina.
P2860
Q25255971-F347D66E-8216-4D48-B3DA-584B2B80A8A5Q26781971-E5B0FC67-5DBB-4EB4-B6EF-6A6FAAEE625CQ26822931-24CA2887-5CA6-4CC9-A16C-6FF8D2D32C99Q26828935-EBC0BDFA-288D-497B-8819-328BF07BFAD5Q27619663-75E8DE98-A8EE-4301-87D5-2EDD4BD3E13FQ27620664-D5FBC979-124E-425F-B37E-70227411416EQ27622030-F5E0937C-CD86-44A0-8197-43DA6CF1CA22Q28344456-F687A4DE-EBC2-445C-A95F-E8C2029A601FQ28369309-B5BAB44B-1179-401F-8A29-3736C2186059Q28371773-C5A4F25F-9513-4B8C-9C98-28E22B55A7ACQ28371775-2E396BDC-3591-4DCD-B8E7-C69AE6FF3CC4Q28371854-0BE57A3E-7E0B-47B0-9B1F-C52F4C71FAFAQ28378710-71E4DAC9-34C5-489B-A55A-7EF762028481Q28379433-45A5DC27-720C-4AFB-94EC-DA470596E187Q33981471-3DE80079-739F-4BD6-8A69-A1032A739515Q34069185-2732CEC4-97D2-4746-9624-B9427FC56F7FQ34260135-3487CB34-F080-47B2-B447-72DEAFE230CFQ34362464-A5FEC081-0348-41E9-B398-F131CF4685AAQ34364712-3415177D-2ED0-4974-A581-48AC3F17D691Q34724499-B258A3DC-2B74-411C-A080-3252D8176632Q34734416-9998AEF4-8D95-4583-A8FA-E1C7AF430080Q35366050-03D03B14-A630-48FB-BEDC-E7A2B79F86D1Q35547253-AC9F530A-B501-46EF-A1A6-F0BF91C89EB2Q35807466-54D644BF-BB30-474A-BF1C-4C2204C0D000Q36106061-F43C5B2C-C295-4701-83A9-04E1E9181EF1Q36106591-B30A5C74-A4FB-43CE-9213-CC899A040297Q36281712-837AB5E6-B976-4EB8-ADAF-581D83235DA9Q36450501-A50DBEDB-3A0B-43DC-9641-CEB2565C22A7Q37431569-1C354179-DBC2-4332-BD6D-A332ABFF04E9Q37557684-0E4BE5CF-F7B2-4E64-99EA-22A6C4E2C301Q37910091-28E2EED6-DEDB-4C14-A7B8-09921C7B0395Q37967462-48852F6D-BD76-48C0-A3EE-39FC074F1379Q38591156-81DBD2EE-456F-4289-B6EF-8A06F0009C93Q38686601-6F7D42D1-9BB7-4164-80E6-3EC4396F0038Q38982524-AB4662BD-5632-4785-8567-DAC079D50436Q40066324-BA3601C2-0FC0-4DCC-BAD9-A2B43010EF54Q40409894-A6D965CF-0100-4E72-B716-1DC5447EF608Q40692182-414E0C18-7B70-4A72-A423-9D813DB95DDAQ40883084-C3E9590F-EC39-483A-A445-601B2AB0BDD3Q41760432-6A3E1C5E-0CF3-4EBD-B263-AFBC0EBD9E31
P2860
Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodies.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Inhibition of HIV replication ...... ells by monoclonal antibodies.
@en
Inhibition of HIV replication ...... ells by monoclonal antibodies.
@nl
type
label
Inhibition of HIV replication ...... ells by monoclonal antibodies.
@en
Inhibition of HIV replication ...... ells by monoclonal antibodies.
@nl
prefLabel
Inhibition of HIV replication ...... ells by monoclonal antibodies.
@en
Inhibition of HIV replication ...... ells by monoclonal antibodies.
@nl
P2093
P356
P1433
P1476
Inhibition of HIV replication ...... ells by monoclonal antibodies.
@en
P2093
Kuebelbeck V
Ledbetter JA
Richman DD
Zarling JM
P2888
P356
10.1038/347092A0
P407
P577
1990-09-01T00:00:00Z
P6179
1004260394